Wells Fargo’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-18,700
Closed -$571K 7116
2024
Q4
$571K Hold
18,700
﹤0.01% 4080
2024
Q3
$429K Hold
18,700
﹤0.01% 4100
2024
Q2
$540K Buy
+18,700
New +$435K ﹤0.01% 3860
2021
Q2
Sell
-5,000
Closed -$763K 7082
2021
Q1
$763K Buy
+5,000
New +$756K ﹤0.01% 4434

Other funds holding GH

Wells Fargo's GH Position: Q1 2026 in Review

Wells Fargo reduced its Guardant Health (GH) stake by 57% in Q1 2026, selling an estimated $12.2M and leaving 92,549 shares worth $8.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2164.

Wells Fargo first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $216M in Q1 2021. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Wells Fargo held 92,549 shares of Guardant Health worth $8.55M as of Q1 2026.
  • Wells Fargo sold 121,628 Guardant Health shares in Q1 2026, an estimated $12.2M.
  • Guardant Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2164 holding.
  • Wells Fargo first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
  • Wells Fargo's Guardant Health position peaked at $216M in Q1 2021.
  • 482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.